From: Diagnostic value of FDG PET-CT in differentiating lung adenocarcinoma from squamous cell carcinoma
Parameters | Total number (percentage) | ADC | SCC | Significance (p value) |
---|---|---|---|---|
Number of patients (n) | 76 | 43 (57%) | 33 (43%) | NA |
Age (Year, Mean ± SD) | 59 ± 9.9 | 59 ± 10.4 | 60 ± 9.3 | 0.633 |
Gender (F/M) | ||||
Female | 15 (20%) | 15 | 0 | NA |
Male | 61 (80%) | 28 | 33 | NA |
Pathologic staging (n) | ||||
Stage 1 | 41 (54%) | 25 | 16 | NA |
Stage 2 | 27 (36%) | 14 | 13 | NA |
Stage 3 | 6 (7%) | 2 | 4 | NA |
Stage 4 | 2 (3%) | 2 | 0 | NA |
TNM Staging | ||||
Stage 1 | 26 (34%) | 18 | 8 | NA |
Stage 2 | 36 (48%) | 18 | 18 | NA |
Stage 3 | 10 (13%) | 5 | 5 | NA |
Stage 4 | 4 (5%) | 2 | 2 | NA |
Lymphovascular invasion (n) | ||||
Positive | 43 (57%) | 27 | 16 | NA |
Negative | 33 (43%) | 16 | 17 | NA |
STAS status | ||||
Positive | 41 (54%) | 31 | 10 | NA |
Negative | 35 (46%) | 12 | 23 | NA |
Lymph node metastasis | ||||
Positive | 14 (18%) | 5 | 9 | NA |
Negative | 37 (49%) | 17 | 20 | NA |
NoS | 25 (33%) | 21 | 4 | NA |
Pleural invasion | ||||
Positive | 17 (22%) | 11 | 6 | NA |
Negative | 59 (78%) | 32 | 27 | NA |